# QuantumScape Corp: overview

QS · Nasdaq · CIK 1811414 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qs.md) · [Financials](/companies/qs/financials.md) · [Filings](/companies/qs/filings.md) · [Insiders](/companies/qs/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [(0.21)](/filings/0001193125-26-177161.md) | [(0.20)](/filings/0001193125-26-316073.md) | [(0.18)](/filings/0001193125-26-430428.md) | not reported | [(0.16)](/filings/0001193125-26-177161.md) | [(0.16)](/filings/0001193125-26-316073.md) | [(0.14)](/filings/0001193125-26-430428.md) |
| Free cash flow | $m | [(69.8) d](/filings/0001193125-26-071556.md) | [(66.6)](/filings/0001193125-26-177161.md) | [(70.4) d](/filings/0001193125-26-316073.md) | [(73.3) d](/filings/0001193125-26-430428.md) | [(68.4) d](/filings/0001193125-26-071556.md) | [(69.5)](/filings/0001193125-26-177161.md) | [(61.4) d](/filings/0001193125-26-316073.md) | [(59.5) d](/filings/0001193125-26-430428.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [(0.52)](/filings/0000950170-24-021100.md) | [(0.95)](/filings/0000950170-25-027308.md) | [(0.96)](/filings/0001193125-26-071556.md) | [(0.94)](/filings/0001193125-26-071556.md) | [(0.76)](/filings/0001193125-26-071556.md) |
| Free cash flow | $m | [(255)](/filings/0000950170-24-021100.md) | [(377)](/filings/0000950170-25-027308.md) | [(325)](/filings/0001193125-26-071556.md) | [(337)](/filings/0001193125-26-071556.md) | [(279)](/filings/0001193125-26-071556.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/qs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $215.9m | 28,560,041 |  | Added +6,750,353 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $159.6m | 21,116,099 |  | Added +239,933 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $141.6m | 18,728,511 |  | Added +701,209 |
| [Capricorn Investment Group LLC](/funds/1536261.md) | 2026-06-30 | $86.9m | 11,496,990 |  | Unchanged |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $66.8m | 8,830,153 |  | Added +483,305 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $62.1m | 8,217,017 |  | Added +662,233 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $56.2m | 7,436,500 | Call | Added +1,554,500 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $55.6m | 7,359,165 |  | Added +2,110,828 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $54.9m | 7,265,875 |  | Reduced −12,476,702 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $53.6m | 7,088,391 |  | Added +1,353,356 |

## Recent filings

[All 994 filings](/companies/qs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:07 ET | [10-Q](/filings/0001193125-26-430428.md) | Quarterly report, period 2026-09-30 | 0001193125-26-430428 |
| 2026-10-21 | 20:18 ET | [8-K](/filings/0001193125-26-427862.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-427862 |
| 2026-07-24 | 20:06 ET | [10-Q](/filings/0001193125-26-316073.md) | Quarterly report, period 2026-06-30 | 0001193125-26-316073 |
| 2026-07-22 | 20:18 ET | [8-K](/filings/0001193125-26-312423.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-312423 |
| 2026-07-22 | 20:02 ET | [8-K](/filings/0001193125-26-312381.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-26-312381 |
| 2026-06-05 | 20:18 ET | [8-K](/filings/0001193125-26-259632.md) | 5.07 Shareholder vote results | 0001193125-26-259632 |
| 2026-04-24 | 20:07 ET | [10-Q](/filings/0001193125-26-177161.md) | Quarterly report, period 2026-03-31 | 0001193125-26-177161 |
| 2026-04-23 | 20:30 ET | [DEF 14A](/filings/0001193125-26-173828.md) | Proxy statement, period 2026-04-23 | 0001193125-26-173828 |
| 2026-04-22 | 20:22 ET | [8-K](/filings/0001193125-26-170507.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-170507 |
| 2026-03-05 | 14:00 ET | [8-K](/filings/0001193125-26-092692.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-092692 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-071556.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1811414
- Tickers: QS
- Exchange: Nasdaq
- SIC code: 3690 Miscellaneous Electrical Machinery, Equipment & Supplies
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.